CYCC - Cyclacel Pharmaceuticals EPS misses by $0.03 February, 26 2020 04:44 PM Cyclacel Pharmaceuticals Inc. Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q4 GAAP EPS of -$0.17 misses by $0.03.More news on: Cyclacel Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...